Preguntas frecuentes

What is Glatiramer Acetate used for?

The acetate salt form of glatiramer, a disease-modifying therapy used to reduce the frequency of relapses in relapsing forms of multiple sclerosis. This polypeptide mixture acts as a decoy for the immune system, diverting the autoimmune attack away from myelin in the nervous system. It is available as a subcutaneous injection given daily or three times per week depending on the formulation.

Is Glatiramer Acetate an approved drug?

Yes, Glatiramer Acetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

• ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201507. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.